Global Pharmaceutical Contract Development and Manufacturing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 318723
  • calendar_today Published On: Jul, 2022
  • file_copy Pages: 165
  • list Medical Devices
Buy @ $3500

The Pharmaceutical Contract Development and Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Pharmaceutical Contract Development and Manufacturing market size is estimated to be worth US$ 124880 million in 2021 and is forecast to a readjusted size of USD 189210 million by 2028 with a CAGR of 6.1% during review period. Big Pharma accounting for % of the Pharmaceutical Contract Development and Manufacturing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pharmaceutical Manufacturing Services segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Pharmaceutical Contract Development and Manufacturing include Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, and Vetter Pharma International GMBH, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Pharmaceutical Contract Development and Manufacturing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Pharmaceutical Manufacturing Services

Biologics Manufacturing Services

Drug Development Services

Market segment by Application, can be divided into

Big Pharma

Small Pharma

Generic Pharma

CRO

Market segment by players, this report covers

Thermo Fisher Scientific Inc.

Catalent, Inc.

Lonza Group Ltd

Recipharm AB

Vetter Pharma International GMBH

FAMAR Health Care Services

AbbVie Inc.

Aenova Group

Consort Medical plc

Almac Group

Siegfried Holding AG

Boehringer Ingelheim International GmbH

Evonik Industries AG

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Pharmaceutical Contract Development and Manufacturing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Pharmaceutical Contract Development and Manufacturing, with revenue, gross margin and global market share of Pharmaceutical Contract Development and Manufacturing from 2019 to 2022.

Chapter 3, the Pharmaceutical Contract Development and Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Contract Development and Manufacturing market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Pharmaceutical Contract Development and Manufacturing research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Pharmaceutical Contract Development and Manufacturing

1.2 Classification of Pharmaceutical Contract Development and Manufacturing by Type

1.2.1 Overview: Global Pharmaceutical Contract Development and Manufacturing Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type in 2021

1.2.3 Pharmaceutical Manufacturing Services

1.2.4 Biologics Manufacturing Services

1.2.5 Drug Development Services

1.3 Global Pharmaceutical Contract Development and Manufacturing Market by Application

1.3.1 Overview: Global Pharmaceutical Contract Development and Manufacturing Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Big Pharma

1.3.3 Small Pharma

1.3.4 Generic Pharma

1.3.5 CRO

1.4 Global Pharmaceutical Contract Development and Manufacturing Market Size & Forecast

1.5 Global Pharmaceutical Contract Development and Manufacturing Market Size and Forecast by Region

1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Pharmaceutical Contract Development and Manufacturing Market Size by Region, (2017-2022)

1.5.3 North America Pharmaceutical Contract Development and Manufacturing Market Size and Prospect (2017-2028)

1.5.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size and Prospect (2017-2028)

1.5.6 South America Pharmaceutical Contract Development and Manufacturing Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharmaceutical Contract Development and Manufacturing Market Drivers

1.6.2 Pharmaceutical Contract Development and Manufacturing Market Restraints

1.6.3 Pharmaceutical Contract Development and Manufacturing Trends Analysis

2 Company Profiles

2.1 Thermo Fisher Scientific Inc.

2.1.1 Thermo Fisher Scientific Inc. Details

2.1.2 Thermo Fisher Scientific Inc. Major Business

2.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.1.4 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans

2.2 Catalent, Inc.

2.2.1 Catalent, Inc. Details

2.2.2 Catalent, Inc. Major Business

2.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.2.4 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Catalent, Inc. Recent Developments and Future Plans

2.3 Lonza Group Ltd

2.3.1 Lonza Group Ltd Details

2.3.2 Lonza Group Ltd Major Business

2.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.3.4 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Lonza Group Ltd Recent Developments and Future Plans

2.4 Recipharm AB

2.4.1 Recipharm AB Details

2.4.2 Recipharm AB Major Business

2.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.4.4 Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Recipharm AB Recent Developments and Future Plans

2.5 Vetter Pharma International GMBH

2.5.1 Vetter Pharma International GMBH Details

2.5.2 Vetter Pharma International GMBH Major Business

2.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.5.4 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Vetter Pharma International GMBH Recent Developments and Future Plans

2.6 FAMAR Health Care Services

2.6.1 FAMAR Health Care Services Details

2.6.2 FAMAR Health Care Services Major Business

2.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.6.4 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 FAMAR Health Care Services Recent Developments and Future Plans

2.7 AbbVie Inc.

2.7.1 AbbVie Inc. Details

2.7.2 AbbVie Inc. Major Business

2.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.7.4 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 AbbVie Inc. Recent Developments and Future Plans

2.8 Aenova Group

2.8.1 Aenova Group Details

2.8.2 Aenova Group Major Business

2.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.8.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Aenova Group Recent Developments and Future Plans

2.9 Consort Medical plc

2.9.1 Consort Medical plc Details

2.9.2 Consort Medical plc Major Business

2.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.9.4 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Consort Medical plc Recent Developments and Future Plans

2.10 Almac Group

2.10.1 Almac Group Details

2.10.2 Almac Group Major Business

2.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.10.4 Almac Group Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Almac Group Recent Developments and Future Plans

2.11 Siegfried Holding AG

2.11.1 Siegfried Holding AG Details

2.11.2 Siegfried Holding AG Major Business

2.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.11.4 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Siegfried Holding AG Recent Developments and Future Plans

2.12 Boehringer Ingelheim International GmbH

2.12.1 Boehringer Ingelheim International GmbH Details

2.12.2 Boehringer Ingelheim International GmbH Major Business

2.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.12.4 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans

2.13 Evonik Industries AG

2.13.1 Evonik Industries AG Details

2.13.2 Evonik Industries AG Major Business

2.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product and Solutions

2.13.4 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Evonik Industries AG Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmaceutical Contract Development and Manufacturing Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharmaceutical Contract Development and Manufacturing Players Market Share in 2021

3.2.2 Top 10 Pharmaceutical Contract Development and Manufacturing Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Pharmaceutical Contract Development and Manufacturing Players Head Office, Products and Services Provided

3.4 Pharmaceutical Contract Development and Manufacturing Mergers & Acquisitions

3.5 Pharmaceutical Contract Development and Manufacturing New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Type (2017-2022)

4.2 Global Pharmaceutical Contract Development and Manufacturing Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application (2017-2022)

5.2 Global Pharmaceutical Contract Development and Manufacturing Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2028)

6.2 North America Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2028)

6.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country

6.3.1 North America Pharmaceutical Contract Development and Manufacturing Revenue by Country (2017-2028)

6.3.2 United States Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

6.3.3 Canada Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

6.3.4 Mexico Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2028)

7.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2028)

7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country

7.3.1 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Country (2017-2028)

7.3.2 Germany Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

7.3.3 France Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

7.3.5 Russia Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

7.3.6 Italy Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2028)

8.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2028)

8.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region

8.3.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Region (2017-2028)

8.3.2 China Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

8.3.3 Japan Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

8.3.4 South Korea Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

8.3.5 India Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

8.3.7 Australia Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2028)

9.2 South America Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2028)

9.3 South America Pharmaceutical Contract Development and Manufacturing Market Size by Country

9.3.1 South America Pharmaceutical Contract Development and Manufacturing Revenue by Country (2017-2028)

9.3.2 Brazil Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

9.3.3 Argentina Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2028)

10.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2028)

10.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country

10.3.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Country (2017-2028)

10.3.2 Turkey Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

10.3.4 UAE Pharmaceutical Contract Development and Manufacturing Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharmaceutical Contract Development and Manufacturing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Pharmaceutical Contract Development and Manufacturing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Pharmaceutical Contract Development and Manufacturing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Pharmaceutical Contract Development and Manufacturing Revenue (USD Million) by Region (2017-2022)

Table 5. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Region (2023-2028)

Table 6. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Thermo Fisher Scientific Inc. Major Business

Table 8. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 9. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Catalent, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Catalent, Inc. Major Business

Table 12. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 13. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Lonza Group Ltd Corporate Information, Head Office, and Major Competitors

Table 15. Lonza Group Ltd Major Business

Table 16. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 17. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Recipharm AB Corporate Information, Head Office, and Major Competitors

Table 19. Recipharm AB Major Business

Table 20. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 21. Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Vetter Pharma International GMBH Corporate Information, Head Office, and Major Competitors

Table 23. Vetter Pharma International GMBH Major Business

Table 24. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 25. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. FAMAR Health Care Services Corporate Information, Head Office, and Major Competitors

Table 27. FAMAR Health Care Services Major Business

Table 28. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 29. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. AbbVie Inc. Corporate Information, Head Office, and Major Competitors

Table 31. AbbVie Inc. Major Business

Table 32. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 33. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Aenova Group Corporate Information, Head Office, and Major Competitors

Table 35. Aenova Group Major Business

Table 36. Aenova Group Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 37. Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Consort Medical plc Corporate Information, Head Office, and Major Competitors

Table 39. Consort Medical plc Major Business

Table 40. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 41. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Almac Group Corporate Information, Head Office, and Major Competitors

Table 43. Almac Group Major Business

Table 44. Almac Group Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 45. Almac Group Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Siegfried Holding AG Corporate Information, Head Office, and Major Competitors

Table 47. Siegfried Holding AG Major Business

Table 48. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 49. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Boehringer Ingelheim International GmbH Corporate Information, Head Office, and Major Competitors

Table 51. Boehringer Ingelheim International GmbH Major Business

Table 52. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 53. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Evonik Industries AG Corporate Information, Head Office, and Major Competitors

Table 55. Evonik Industries AG Major Business

Table 56. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product and Solutions

Table 57. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Pharmaceutical Contract Development and Manufacturing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Pharmaceutical Contract Development and Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Pharmaceutical Contract Development and Manufacturing Players Head Office, Products and Services Provided

Table 62. Pharmaceutical Contract Development and Manufacturing Mergers & Acquisitions in the Past Five Years

Table 63. Pharmaceutical Contract Development and Manufacturing New Entrants and Expansion Plans

Table 64. Global Pharmaceutical Contract Development and Manufacturing Revenue (USD Million) by Type (2017-2022)

Table 65. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Type (2017-2022)

Table 66. Global Pharmaceutical Contract Development and Manufacturing Revenue Forecast by Type (2023-2028)

Table 67. Global Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2022)

Table 68. Global Pharmaceutical Contract Development and Manufacturing Revenue Forecast by Application (2023-2028)

Table 69. North America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Pharmaceutical Contract Development and Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Pharmaceutical Contract Development and Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Pharmaceutical Contract Development and Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Pharmaceutical Contract Development and Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Pharmaceutical Contract Development and Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Pharmaceutical Contract Development and Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Pharmaceutical Contract Development and Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Pharmaceutical Contract Development and Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Pharmaceutical Contract Development and Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Pharmaceutical Contract Development and Manufacturing Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Pharmaceutical Contract Development and Manufacturing Picture

Figure 2. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type in 2021

Figure 3. Pharmaceutical Manufacturing Services

Figure 4. Biologics Manufacturing Services

Figure 5. Drug Development Services

Figure 6. Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application in 2021

Figure 7. Big Pharma Picture

Figure 8. Small Pharma Picture

Figure 9. Generic Pharma Picture

Figure 10. CRO Picture

Figure 11. Global Pharmaceutical Contract Development and Manufacturing Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Pharmaceutical Contract Development and Manufacturing Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Region (2017-2028)

Figure 14. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Region in 2021

Figure 15. North America Pharmaceutical Contract Development and Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Pharmaceutical Contract Development and Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Pharmaceutical Contract Development and Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Pharmaceutical Contract Development and Manufacturing Market Drivers

Figure 21. Pharmaceutical Contract Development and Manufacturing Market Restraints

Figure 22. Pharmaceutical Contract Development and Manufacturing Market Trends

Figure 23. Thermo Fisher Scientific Inc. Recent Developments and Future Plans

Figure 24. Catalent, Inc. Recent Developments and Future Plans

Figure 25. Lonza Group Ltd Recent Developments and Future Plans

Figure 26. Recipharm AB Recent Developments and Future Plans

Figure 27. Vetter Pharma International GMBH Recent Developments and Future Plans

Figure 28. FAMAR Health Care Services Recent Developments and Future Plans

Figure 29. AbbVie Inc. Recent Developments and Future Plans

Figure 30. Aenova Group Recent Developments and Future Plans

Figure 31. Consort Medical plc Recent Developments and Future Plans

Figure 32. Almac Group Recent Developments and Future Plans

Figure 33. Siegfried Holding AG Recent Developments and Future Plans

Figure 34. Boehringer Ingelheim International GmbH Recent Developments and Future Plans

Figure 35. Evonik Industries AG Recent Developments and Future Plans

Figure 36. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Players in 2021

Figure 37. Pharmaceutical Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Pharmaceutical Contract Development and Manufacturing Revenue Market Share in 2021

Figure 39. Global Top 10 Players Pharmaceutical Contract Development and Manufacturing Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Type in 2021

Figure 42. Global Pharmaceutical Contract Development and Manufacturing Market Share Forecast by Type (2023-2028)

Figure 43. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Application in 2021

Figure 44. Global Pharmaceutical Contract Development and Manufacturing Market Share Forecast by Application (2023-2028)

Figure 45. North America Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2017-2028)

Figure 46. North America Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2017-2028)

Figure 47. North America Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Country (2017-2028)

Figure 48. United States Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2017-2028)

Figure 52. Europe Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2017-2028)

Figure 53. Europe Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Country (2017-2028)

Figure 54. Germany Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Region (2017-2028)

Figure 62. China Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2017-2028)

Figure 69. South America Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2017-2028)

Figure 70. South America Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source